Saturday, September 07, 2013 3:21:12 PM
I think too many people have had excessive pps expectation incl. Shadow, Tappy, and others. Reality is much of the FdA approval (potential) is mostly priced in already.
I too think we might hit $5 plus in pre hour trading on the day of approval, but not likely to sustain during regular hours....at end of year my expectation is low 5 at best...
With some material news on QST, QSM, Pfeizer collaboration, and international collaboration, we might see some pops but ultimately sustainable pop won't be until revenue confirmation and when we become profitable entity.
Scott Matusow still thinks we will get bought out soon after fda approval... Personally i would be all for it. I know most of you don't think the management will sell, but then again Atrs management - same ones doing monthly selling their shares - may do it for various reasons we the small investors don't understand or agree with.
I m beginning to think the chance for acquisition is good.. I hate agreeing w. Matusow but i actually do.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM